Aquestive Therapeutics Inc (NASDAQ:AQST)
| 0.8849 Delayed Data As of 12:05pm ET |  -0.0051 / -0.57%Today’s Change | 0.62 Today|||52-Week Range 3.19 | -1.91% Year-to-Date |
Latest AQST News | Press Releases
No recent news for Aquestive Therapeutics Inc.
Today’s Trading
| Previous close | 0.89 |
| Today’s open | 0.90 |
| Day’s range | 0.88 - 0.90 |
| Volume | 300 |
| Average volume (3 months) | 472,127 |
| Market cap | $54.7M |
Data as of 12:05pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -11.75% |
| Earnings growth (this year) | +43.47% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +10.87% |
| P/E ratio | NM |
| Price/Sales | 2.91 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TXMDTherapeuticsMD Inc | +0.23 | +4.53% |
| ELDNEledon Pharmaceutica... | 0.00 | 0.00% |
| CKPTCheckpoint Therapeut... | -0.13 | -2.52% |
| LPCNLipocine Inc | +0.01 | +2.60% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $50.8M |
| Annual profit (last year) | -$70.5M |
| Net profit margin | -138.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
